MAM
SAMCO Securities launches its new latest TVC
Mumbai: SAMCO Securities, an investment-tech company, has launched a new TVC campaign titled “Options B.R.O. Banayega Aapko Options Trading Mein Pro”. This campaign is designed to educate investors and raise awareness about SAMCO’s latest feature, “Options B.R.O” (build, research, optimise) which simplifies options trading for retail investors.
The derivative markets face a troubling issue: a staggering 97.8 per cent of traders have suffered significant losses due to the absence of effective hedging strategies. To bring awareness about this problem, SAMCO Securities has launched the campaign ‘Options B.R.O. Banayega Aapko Options Trading Mein Pro’. The campaign is created in collaboration with The Womb. The centerpiece of this initiative is a 30-second commercial that uses humour to highlight the challenges of options trading and demonstrate how Options B.R.O. can provide the necessary education and tools to overcome them.
SAMCO Group founder and CEO Jimeet Modi commented, “Options trading can be incredibly challenging and intimidating, especially for those just starting. With Options B.R.O, we aim to simplify the process and provide traders with the essential tools and their trade’s Andekha Sach that help them to navigate the complexities of options trading and trade with confidence.”
‘Options B.R.O.’ campaign is a unique film featuring a man and a crow. In the film, the man, dressed in traditional attire, wonders aloud about becoming a pro in options trading. The crow responds with a series of ‘Kaw Kaw’ sounds, reflecting a common concern among traders. The man then enthusiastically reveals that with SAMCO’s ‘Options B.R.O.’ becoming an expert in options trading is now within reach. As the crow starts enjoying the food, the film underscores how SAMCO’s innovative platform transforms options trading into an accessible and empowering experience. The campaign reinforces SAMCO’s promise with the tagline, “Aapke Options Trading Ka Andheka Sach” (The unseen truth of options trading).
SAMCO Securities chief growth officer Ajay Dusane added by saying, “The introduction of Options B.R.O is set to make a significant impact in the trading industry. We anticipate that this feature will be warmly received by traders, providing them with the resources they need to trade options with confidence and precision. It’s a game-changer that aligns with our mission to empower traders with their trade’s Andekha Sach and foster growth in the trading community.”
The Womb chief creative officer Suyash Khabya said, “Options Trading is complicated. Its advertising shouldn’t be. We kept it simple yet ‘unignorable’ by drawing on Indian culture—a grandson conversing with his Dadu, who is a crow. This creative approach aims to engage traders and highlight the benefits of Options B.R.O. We’ve always enjoyed creating ads for SAMCO, and it shows in our work.”
The Options B.R.O feature is now available on the SAMCO Trading App, ready to empower traders with the tools they need to excel in the competitive world of options trading. With this new addition, SAMCO continues its commitment to providing unseen insights that drive success for traders at all levels.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
